1. Home
  2. WEST vs TBPH Comparison

WEST vs TBPH Comparison

Compare WEST & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westrock Coffee Company

WEST

Westrock Coffee Company

HOLD

Current Price

$8.18

Market Cap

812.3M

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$17.05

Market Cap

908.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEST
TBPH
Founded
2009
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.3M
908.9M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
WEST
TBPH
Price
$8.18
$17.05
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$7.00
$18.40
AVG Volume (30 Days)
238.6K
365.5K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
279.13
EPS
N/A
N/A
Revenue
$1,188,952,000.00
$15,386,000.00
Revenue This Year
$11.27
$8.46
Revenue Next Year
$10.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.76
N/A
52 Week Low
$3.59
$13.08
52 Week High
$10.19
$21.03

Technical Indicators

Market Signals
Indicator
WEST
TBPH
Relative Strength Index (RSI) 53.31 57.96
Support Level $7.65 $16.80
Resistance Level $8.58 $17.11
Average True Range (ATR) 0.28 0.05
MACD 0.01 -0.01
Stochastic Oscillator 75.00 21.57

Price Performance

Historical Comparison
WEST
TBPH

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States. Additionally, it offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice, restaurant, convenience store, travel center, non-commercial account, and hospitality industries around the world. The company's reportable segments are: Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment, which offers beverage solutions, including coffee, tea, flavors, extracts, and ingredients. Geographically, the company generates maximum revenue from its business in the United States and the rest from other countries.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: